Hospital‐level balloon tamponade use is associated with increased mortality for all patients presenting with acute variceal haemorrhage
dc.contributor.author | Tapper, Elliot B. | |
dc.contributor.author | Ezaz, Ghideon | |
dc.contributor.author | Patwardhan, Vilas | |
dc.contributor.author | Mellinger, Jessica | |
dc.contributor.author | Bonder, Alan | |
dc.contributor.author | Curry, Michael | |
dc.contributor.author | Saini, Sameer D. | |
dc.date.accessioned | 2018-03-07T18:25:54Z | |
dc.date.available | 2019-05-13T14:45:25Z | en |
dc.date.issued | 2018-03 | |
dc.identifier.citation | Tapper, Elliot B.; Ezaz, Ghideon; Patwardhan, Vilas; Mellinger, Jessica; Bonder, Alan; Curry, Michael; Saini, Sameer D. (2018). "Hospital‐level balloon tamponade use is associated with increased mortality for all patients presenting with acute variceal haemorrhage." Liver International 38(3): 477-483. | |
dc.identifier.issn | 1478-3223 | |
dc.identifier.issn | 1478-3231 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/142540 | |
dc.description.abstract | Background & AimsBalloon tamponade (BT) can bridge patients to salvage therapy for uncontrollable acute variceal haemorrhage (AVH). However, data are limited regarding the reasons for, rate of and outcomes associated with Balloon tamponade use.MethodsFirst, we performed an single‐centre cohort study of all patients (N = 139) with oesophageal acute variceal haemorrhage from 01/2009 to 10/2015. Associations between Balloon tamponade use and adherence to four quality metrics (endoscopy within 12 hours, band‐ligation, pre‐endoscopy antibiotics and octreotide) were evaluated. Second, we analysed the National Inpatient Sample (2005‐2011) to determine the association between in‐hospital mortality for patients and their hospital’s Balloon tamponade—utilization to acute variceal haemorrhage volume ratio.ResultsIn the national cohort, 5.5% of 140 521 acute variceal haemorrhage admissions required Balloon tamponade utilization. Adjusting for patient‐ and hospital‐level confounders, the rate of Balloon tamponade use per acute variceal haemorrhage managed at any given hospital was associated with increased mortality for all‐comers with acute variceal haemorrhage. Compared to the lowest tertile, acute variceal haemorrhage admissions in the highest Balloon tamponade utilizers were associated with increased mortality of (OR1.17 95%CI (1.01‐1.37).In the single‐centre cohort, 14 (10.1%) patients required Balloon tamponade. Balloon tamponade utilization was significantly associated with alcohol abuse (50.4% vs 21.4%, P = .04), hepatocellular carcinoma (35.7% vs 8.8%, P = .01), higher median model for end‐stage liver disease (MELD) score (26.3vs15.5, P = .002) and active bleeding during endoscopy (64.3% vs 27.5%, P = .01). Failure to provide all quality metrics was associated with a higher model for end‐stage liver disease‐adjusted risk of Balloon tamponade use: OR 16.7 95% CI(4.17‐100.0, P < .0001).ConclusionBalloon tamponade use is associated with severity of bleeding but may also implicate deficits in processes of care. Even for patients who did not need Balloon tamponade, presentation to hospitals with high Balloon tamponade utilization increases their odds of dying from acute variceal haemorrhage. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | model for end‐stage liver disease score | |
dc.subject.other | liver disease | |
dc.subject.other | cirrhosis | |
dc.subject.other | endoscopy | |
dc.subject.other | portal hypertension | |
dc.title | Hospital‐level balloon tamponade use is associated with increased mortality for all patients presenting with acute variceal haemorrhage | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/142540/1/liv13559.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/142540/2/liv13559_am.pdf | |
dc.identifier.doi | 10.1111/liv.13559 | |
dc.identifier.source | Liver International | |
dc.identifier.citedreference | El‐Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11‐year period in the Department of Veterans Affairs. Am J Gastroenterol. 2000; 95: 3566 ‐ 3573. | |
dc.identifier.citedreference | Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004; 40: 652 ‐ 659. | |
dc.identifier.citedreference | de Franchis R, Faculty BV. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015; 63: 743 ‐ 752. | |
dc.identifier.citedreference | Tapper EB, Beste L, Curry M, Bonder A, Waljee A, Saini S. Suboptimal Implementation of Evidence‐based Therapy for Acute Variceal Hemorrhage: A Systematic Review of Observational Studies. Clin Gastroenterol Hepatol. 2017; 15: 1373 ‐ 1381. | |
dc.identifier.citedreference | Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol. 2003; 98: 653 ‐ 659. | |
dc.identifier.citedreference | Altraif I, Handoo FA, Aljumah A, et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double‐blind, placebo‐controlled trial. Gastrointest Endosc. 2011; 73: 245 ‐ 250. | |
dc.identifier.citedreference | Wundke R, Altus R, Sandford J, et al. Improving management of oesophageal varices in patients with cirrhosis. Qual Saf Health Care. 2010; 19: 536 ‐ 541. | |
dc.identifier.citedreference | Johnson E, Spier B, Leff J, et al. Optimising the care of patients with cirrhosis and gastrointestinal haemorrhage: a quality improvement study. Aliment Pharmacol Ther. 2011; 34: 76 ‐ 82. | |
dc.identifier.citedreference | Mayorga CA, Rockey DC. Clinical utility of a standardized electronic order set for the management of acute upper gastrointestinal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol. 2013; 11: 1342 ‐ 1348. | |
dc.identifier.citedreference | Sarwar A, Zhou L, Novack V, et al. Hospital volume and mortality after trans‐jugular intrahepatic portosystemic shunt creation in the United States. Hepatology. 2017. [Epub ahead of print]. https://doi.org/10.1002/hep.29354 | |
dc.identifier.citedreference | Kanwal F, Kramer J, Asch SM, et al. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010; 8: 709 ‐ 717. | |
dc.identifier.citedreference | Tapper EB, Friderici J, Borman ZA, et al. A multicenter evaluation of baveno guideline adherence and outcomes for patients with acute variceal hemorrhage. J Clin Gastroenterol. 2017. [Epub ahead of print]. https://doi.org/10.1097/MCG.0000000000000820 | |
dc.identifier.citedreference | Tapper EB. Building effective quality improvement programs in liver disease: a systematic review of quality improvement initiatives. Clin Gastroenterol Hepatol. 2016; 14: 1256 ‐ 1265. | |
dc.identifier.citedreference | Shukla R, Kramer J, Cao Y, et al. Risk and predictors of variceal bleeding in cirrhosis patients receiving primary prophylaxis with non‐selective beta‐blockers. Am J Gastroenterol. 2016; 111: 1778 ‐ 1787. | |
dc.identifier.citedreference | Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993; 80: 27 ‐ 38. | |
dc.identifier.citedreference | Hauser TH, Ho KK. Accuracy of on‐line databases in determining vital status. J Clin Epidemiol. 2001; 54: 1267 ‐ 1270. | |
dc.identifier.citedreference | Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD‐9‐CM administrative databases. J Clin Epidemiol. 1992; 45: 613 ‐ 619. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.